ELN » Topics » 35 Subsidiary Undertakings

This excerpt taken from the ELN 6-K filed Mar 30, 2007.
35 Subsidiary Undertakings
 
At 31 December 2006, we had the following principal subsidiary undertakings:
 
                 
              Registered Office &
        Group
    Country of Incorporation
Company   Nature of Business   Share %     Operation
 
Athena Neurosciences, Inc. 
  Holding company     100     800 Gateway Blvd South San Francisco, CA United States
Elan Capital Corp., Ltd. 
  Financial services company     100     Clarendon House 2 Church St Hamilton, Bermuda
Elan Drug Delivery, Inc. 
  R&D     100     3000 Horizon Drive King of Prussia, PA United States
Elan Finance plc
  Financial services company     100     Treasury Building Lower Grand Canal Street Dublin 2, Ireland
Elan Holdings, Inc. 
  Manufacture of pharmaceutical and medical device products     100     1300 Gould Drive Gainesville, GA United States
Elan Holdings Ltd. 
  Holding company     100     Monksland, Athlone Co. Westmeath, Ireland
Elan International Services Ltd. 
  Financial services company     100     Clarendon House 2 Church St Hamilton, Bermuda
Elan Management Ltd. 
  Provision of management services     100     Treasury Building Lower Grand Canal Street Dublin 2, Ireland
Elan Pharma International Ltd. 
  R&D, manufacture, sale and distribution of pharmaceutical products and financial services     100     Monksland, Athlone Co. Westmeath, Ireland
Elan Pharmaceuticals, Inc. 
  R&D and sale of pharmaceutical products     100     800 Gateway Blvd South San Francisco, CA United States
Monksland Holding BV
  Financial services company     100     Amsteldijk 166 6th Floor 1079 LH Amsterdam The Netherlands
Neuralab Ltd. 
  Non-trading     100     Clarendon House 2 Church St Hamilton, Bermuda
                 
 
Information regarding all other subsidiaries will be filed with our next annual return as provided for by Section 16(3)(a) of the Companies (Amendment) Act, 1986.
 
36  Critical Accounting Policies
 
Our critical accounting policies are set out on pages 31 to 37 of the Annual Report.
 
37  Approval of Consolidated Financial Statements
 
The Consolidated Financial Statements were approved by the directors on 28 March 2007.
 
134 Elan Corporation, plc 2006 Annual Report


Table of Contents

 
 
US GAAP Information
 
 
The financial statements of the Company have been prepared in accordance with IFRS as adopted by the European Union, which differs in certain significant respects from US GAAP.
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki